Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9650342 Compositions and methods of treating retinal disease

Patent 9650342 was granted and assigned to Aldeyra Therapeutics on May, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128013 Toxic aldehyde related diseases and treatment
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064516 Pharmaceutical formulations and uses thereof
0
Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006298 Polymorphic compounds and uses thereof
0
Edits on 6 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 6 Dec, 2023
Edits made to:
Article (+270 characters)
Article

Patent abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Edits on 18 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11786518 Ophthalmic formulations and uses thereof
Edits on 4 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11771664 Toxic aldehyde related diseases and treatment
Edits on 19 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11701331 Toxic aldehyde related diseases and treatment
0
Edits on 20 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09650342 Compositions and methods of treating retinal disease US Patent 9650342 Compositions and methods of treating retinal disease

Infobox
Patent Number
0965034200
Patent Number
965034200
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0965034200
Edits on 29 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Current Assignee
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
096503420
Date of Patent
May 16, 2017
0
Patent Application Number
150498900
Date Filed
February 22, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=096503420
Patent Primary Examiner
‌
Wu-Cheng Winston Shen
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Current Assignee
Aldeyra Therapeutics
Aldeyra Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
096503420
Date of Patent
May 16, 2017
0
Patent Application Number
150498900
Date Filed
February 22, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=096503420
Patent Primary Examiner
‌
Wu-Cheng Winston Shen
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09650342
Edits on 12 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09650342 Compositions and methods of treating retinal disease

Infobox
Is a
Patent
Patent
Patent applicant
Aldeyra Therapeutics
Aldeyra Therapeutics
Current assignee
Aldeyra Therapeutics
Aldeyra Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09650342
Date of patent
May 16, 2017
Patent application number
15049890
Date Filed
February 22, 2016
Patent primary examiner
‌
Wu-Cheng Winston Shen

Find more entities like US Patent 9650342 Compositions and methods of treating retinal disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo